Your browser doesn't support javascript.
loading
Olfactory Function in SCA10.
Moscovich, Mariana; Munhoz, Renato Puppi; Moro, Adriana; Raskin, Salmo; McFarland, Karen; Ashizawa, Tetsuo; Teive, Helio A G; Silveira-Moriyama, Laura.
Afiliação
  • Moscovich M; Movement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil. marimoscovich@hotmail.com.
  • Munhoz RP; Department of Neurology, UKSH, Campus Kiel, Christian-Albrechts-University, Kiel, Germany. marimoscovich@hotmail.com.
  • Moro A; Movement Disorders Centre, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
  • Raskin S; Movement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil.
  • McFarland K; Group for Advanced Molecular Investigation (NIMA), School of Health and Biosciences, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná, Brazil.
  • Ashizawa T; Department of Neurology, UKSH, Campus Kiel, Christian-Albrechts-University, Kiel, Germany.
  • Teive HAG; Department of Neurology, Houston Methodist, Weill Cornell Medical College, Houston, TX, USA.
  • Silveira-Moriyama L; Movement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil.
Cerebellum ; 18(1): 85-90, 2019 Feb.
Article em En | MEDLINE | ID: mdl-29922950
ABSTRACT
Although the main clinical manifestations of spinocerebellar ataxias (SCAs) result from damage of the cerebellum, other systems may also be involved. Olfactory deficits have been reported in other types of ataxias, especially in SCA3; however, there are no studies on olfactory deficits in SCA type 10 (SCA10). To analyze olfactory function of SCA10 patients compared with that of SCA3, Parkinson's, and healthy controls. Olfactory identification was tested in three groups of 30 patients (SCA10, SCA3, and Parkinson's disease (PD)) and 44 healthy controls using the Sniffin' Sticks (SS16) test. Mean SS16 score was 11.9 ± 2.9 for the SCA10 group, 12.3 ± 1.9 for the SCA3 group, 6.6 ± 2.8 for the PD group, and 12.1 ± 2.0 for the control group. Mean SS16 score for the SCA10 group was not significantly different from the scores for the SCA3 and control groups but was significantly higher than the score for the PD group (p < 0.001) when adjusted for age, gender, and history of smoking. There was no association between SS16 scores and disease duration in the SCA10 or SCA3 groups or number of repeat expansions. SS16 and Mini Mental State Examination scores were correlated in the three groups SCA10 group (r = 0.59, p = 0.001), SCA3 group (r = 0.50, p = 0.005), and control group (r = 0.40, p = 0.007). We found no significant olfactory deficits in SCA10 in this large series.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Olfato / Doença de Machado-Joseph / Ataxias Espinocerebelares / Transtornos do Olfato Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Cerebellum Assunto da revista: CEREBRO Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Olfato / Doença de Machado-Joseph / Ataxias Espinocerebelares / Transtornos do Olfato Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Cerebellum Assunto da revista: CEREBRO Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil